Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

OBJECTIVE: WHO recommends ritonavir-boosted protease inhibitor with two nucleoside reverse transcriptase inhibitors in HIV-infected patients failing non-nucleoside reverse transcriptase inhibitor-based first-line treatment. Here, we aimed to provide more evidence for the choice of nucleoside reverse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIDS
Autors principals: Ciaffi, Laura, Koulla-Shiro, Sinata, Sawadogo, Adrien, le Moing, Vincent, Eymard-Duvernay, Sabrina, Izard, Susanne, Kouanfack, Charles, Ngom Gueye, Ndeye Fatou, Fobang, Avelin Aghokeng, Reynes, Jacques, Calmy, Alexandra, Delaporte, Eric
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2015
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4502989/
https://ncbi.nlm.nih.gov/pubmed/26244387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000709
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars